Mallinckrodt’s Bankruptcy Plan Would Cut Payments to Opioid Victims by $1 Billion

The New York Times - Business:

Mallinckrodt Pharmaceuticals had promised $1.7 billion to governments, individuals and others harmed by the opioid crisis.

Author: Rebecca Robbins

This post first appeared in The New York Times - Business. Read the original article.